Академический Документы
Профессиональный Документы
Культура Документы
■
description of the suggested quality indicator to be measured. The
definitions are intentionally broad to allow for local needs in defining
eligible patients. Given the state of evidence, it is entirely possible that
some of these evidence-based process measures will be under debate
PROCES as you review this table.
S ■
Given the limitations in studying outcomes or structure as measures
of OUTCOM
quality, process of care seems like an appealing option. Process
measures have intuitive appeal to clinicians who may find data
showing that they are not doing something they believe they should E
be more compelling than recommendations about structure of the Mortality, despite its limitations, will always remain high on the list
ICU or risk-adjusted mortality. It also seems a clearer way to address of
a clinical behavior than other quality reports. Finally, for statistical quality measures stakeholders request when discussing quality. For
reasons it is easier to moni- tor changes in more common processes obvi- ous reasons, crude mortality is inadequate to assess this
than in rare events like death or VAP. Selecting process measures, outcome, and intensive care has led the field of risk adjustment for
particularly in critical care, presents some challenges. Ideally process decades.132-134 Scoring systems have helped us simplify our
measures should be linked with com- pelling, usually randomized epidemiological description of criti- cally ill patients and adjust for
trial, evidence of a direct effect on outcome. These evidence-based confounding due to severity of illness in research; however, they have
process indicators may be referred to as outcome validated and not been validated to be used for (1) bench- marking40 or (2)
represent direct measures of quality.126 Unfortunately, there is scarce identification of low performing units.34 One important question
availability of indicators that have been robustly validated in critical remains to be answered: Is it useful to monitor mortality over time as
care. Even processes of care based on large randomized clini- cal trials, a quality improvement strategy in individual units? Intensivists
such as low tidal volume ventilation for acute lung injury,127 have been advocate for several different methods of longitudinal follow-up,
disputed in the literature.128 This is the very nature of science and to including serial standardized mortality ratios (SMRs), risk-adjusted p
expect 100% agreement would break the safeguard against col- lective charts, risk- adjusted CUSUM charts, and other approaches.135
error that derives from differences in opinion.129 Although not unique However, to date there are no data to validate the use of longitudinal
to critical care, developing strict process measures of quality of care SMRs to monitor quality.
will always be difficult as the evidence base is modest and evolving. What makes risk-adjusted mortality unsuitable to be used as a
Glucose control and renal dose dopamine are just a few of the quality indicator?
treatments that might have made excellent process measures of
quality until they were shown to be ineffective or harmful. 1. SMRs can change due to factors unrelated to the quality of care,
There is a bit of confusion in the literature regarding what processes such as the way laboratory values and vital signs are recorded. In
of care means. Examples of processes of care include deep venous an elegant study, patients had laboratory values and vital signs
throm- bosis prophylaxis, sedation interruption strategies, daily recorded at ICU admission and then as per clinical indication
assessment of readiness to wean, head of bed elevation, assessment for (standard mea- surement), concomitantly, the authors measured
early enteral nutrition, compliance with evidence-based protocols, use laboratory values every 2 hours and vitals whenever they were
of continu- ous subglottic aspiration, stress ulcer prophylaxis, and low abnormal (intensive measurement). The intensive measurements
tidal volume ventilation. Practices that are frequently cited as led to absolute SMRs
processes of care, but that we do not consider as such, include length 10% lower than the standard measurements, in both APACHE II
of ICU stay, proportion of occupied beds, duration of mechanical and SAPS II.136 An ICU using more intensive measurement will look
ventilation,130 plateau airway better than one that uses standard measurement, even when no real
differences exist because the more intensive monitoring yields
more
pressures below 30 cm H2O,131 and central venous saturation above extreme values for severity of illness variables.
70%.131 The reason for not considering these as processes of care risk adjust the results to the patient population.
indica-
tors is that they are confounded by patients’ characteristics and are not
under the exclusive control of providers. It is easy to understand
this concept when we discuss ICU length of stay or duration of
mechanical ventilation. These end points are clearly influenced by more
than just our clinical processes of care and cannot be compared across
patients and/ or centers without appropriate risk adjustment.
However, it is harder to understand why physiologic targets of
appropriate treatments are not ideal process of care variables. For
example, lung protective ventilation for ARDS using one protocol
prescribes the tidal volume and a target plateau pressure. The
physician has complete control over setting the tidal volume, however,
the resulting plateau pressure reflects a complex interaction between
the process measure (tidal volume) and patient fac- tors like thoracic
compliance. Ideally, the quality measure would capture the attempt of
the physician to respond to the plateau pressure and titrate the tidal
volume, but this is difficult to measure. There is nothing wrong with
including physiologic targets of evidence-based processes like plateau
pressure, central venous saturation, or sedation scores as quality
measures, however, they lack one of the basic advantages of process
measures, specifically, insensitivity to patient factors and risk
adjustment. Therefore, if an ICU looks bad because their patients tend
not to achieve some physiologic targets, this might be due to failure
to adequately implement the process of care or it might be due to age,
obesity, severity of illness, or any of a number of patient factors. If
physi- ologic targets of evidence-based process measures are included
in qual- ity assessments, some thought should be given to the need to
2. Differences in case mix may lead to differences in the estimate of
the SMR. Even though risk-adjusted models are supposed to deal
with different patient characteristics, they are still far from
perfectly calibrated. In fact, changing the severity of the case mix
leads to differences in the SMR even when there are no real
differences in observed outcome per category. In one study, the
SMR was catego- rized by mortality risk, with a cutoff of 10%
risk.137 Patients with lower risk had SMRs above 2, while those
with higher predicted risk had SMRs close to 1. Obviously, units
with higher percentage of low-risk patients may look worse than
units that care only for sicker patients. This effect is also
expected with different popula- tions where the model may
calibrate differently in different patient subsets. Therefore, even
though risk-adjustment models were devel- oped to allow for
comparisons of different groups of patients, their imperfect
calibration makes this use challenging.